PODD

Insulet Corp
D

PODD

301.15
USD
-0.21
(-0.07%)
مغلق
حجم التداول
17,541
الربح لكل سهم
4
العائد الربحي
-
P/E
54
حجم السوق
21,193,408,061
أصول ذات صلة
ABT
ABT
0.210
(0.16%)
134.280 USD
BSX
BSX
0.625
(0.60%)
104.250 USD
DXCM
DXCM
-0.640
(-0.77%)
82.920 USD
EW
EW
-0.480
(-0.62%)
76.540 USD
ILMN
ILMN
0.360
(0.36%)
100.710 USD
ISRG
ISRG
3.16
(0.58%)
543.88 USD
MDT
MDT
-0.114
(-0.13%)
88.220 USD
SYK
SYK
-5.11
(-1.30%)
386.66 USD
T
TNDM
-0.275
(-1.61%)
16.785 USD
المزيد
الأخبار المقالات

العنوان: Insulet Corp

القطاع: Healthcare
الصناعة: Medical Devices
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.